YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Sandu Pharma
Sandu Pharma
BSE: 524703NSE: ISIN: INE751D01014

17th-Apr-2021 10:57Source: BSE

Sandu Pharmaceuticals - Statement Of Investor Complaints For The Quarter Ended March 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0761
Name of the Signatory :- PRATIKA MHAMBRAY
Designation :- Company Secretary and Compliance Officer

More Announcements on:

Sections